These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 787905)

  • 1. [Use of hemostatic preparations in obstetrical hemorrhages].
    Pavlovskiĭ DP; Mikaĭlenko ET
    Pediatr Akus Ginekol; 1976; (1):33-7. PubMed ID: 787905
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemostatic disorders in obstetrics and their correction].
    Mikhaĭlenko ET; Pavlovskĭ DP
    Pediatr Akus Ginekol; 1977; (2):33-8. PubMed ID: 329201
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case contribution to the therapy of obstetrical afibrinogenemia].
    Pleissner K
    Z Arztl Fortbild (Jena); 1967 Dec; 61(24):1297-9. PubMed ID: 5591403
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contrykal as antifibrinolytic agent in obstetrics and gynecology].
    Flähmig M; Sieg U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):142-50. PubMed ID: 4174652
    [No Abstract]   [Full Text] [Related]  

  • 5. Antifibrinolytics gynaecology and obstetrics.
    Koutský J; Hladovec J
    Acta Univ Carol Med (Praha); 1975; 21(5-6):235-386. PubMed ID: 132853
    [No Abstract]   [Full Text] [Related]  

  • 6. [Thrombolytic treatment in pregnancy and during labor].
    Brandt M; Niedner W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):477-82. PubMed ID: 63436
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of the disseminated intravascular coagulation syndrome in obstetrical practice].
    Repina MA
    Akush Ginekol (Mosk); 1979 Mar; (3):3-6. PubMed ID: 373481
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of blood coagulation disorders].
    Porchia NL
    Matern Infanc (Sao Paulo); 1968; 27(4):349-55. PubMed ID: 5728525
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical use of hemostatic agents.
    Lowe GD; Lawson DH
    J Maine Med Assoc; 1978 Mar; 69(3):87-97. PubMed ID: 650082
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antifibrinolytic agents and anticoagulants in disseminated intravascular coagulation, with particular regard to embolism of the amniotic fluid and hemorrhage in gynecology].
    Koutský J
    Cesk Gynekol; 1971 Apr; 36(3):140-1. PubMed ID: 5314511
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen concentrate use during major obstetric haemorrhage.
    Glover NJ; Collis RE; Collins P
    Anaesthesia; 2010 Dec; 65(12):1229-30. PubMed ID: 21182609
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of antifibrinolytic agents in obstetrics].
    Vojta M
    Cesk Gynekol; 1970 Jul; 35(6):384-6. PubMed ID: 5311001
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemorrhages caused by hyperfibrinolysis and their treatment].
    Teofili MT; Tucci G
    Clin Ter; 1968 Sep; 46(6):563-84. PubMed ID: 4914362
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemorrhagic complications caused by coagulation disorders in retention of the dead fetus].
    Avanzini S; Orrù A; Malacrida V
    Minerva Ginecol; 1969 Apr; 21(8):476-86. PubMed ID: 5306033
    [No Abstract]   [Full Text] [Related]  

  • 15. Amicar and hyperfibrinolysis.
    Med Lett Drugs Ther; 1967 Jan; 9(3):10-1. PubMed ID: 6067964
    [No Abstract]   [Full Text] [Related]  

  • 16. [The therapy of acute blood loss in puerperae].
    Kuznetsov VP
    Feldsher Akush; 1989 Dec; 54(12):5-7. PubMed ID: 2697599
    [No Abstract]   [Full Text] [Related]  

  • 17. [A contribution to diagnosis and therapy of blood coagulation during labor].
    Burkhardt H; Schilling W
    Zentralbl Gynakol; 1966 Feb; 88(6):145-53. PubMed ID: 5299035
    [No Abstract]   [Full Text] [Related]  

  • 18. [Different forms of utilization coagulopathy and their treatment].
    Herschlein HJ; Steichele DF
    Med Welt; 1969 Nov; 44():2389-98. PubMed ID: 4915798
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinolytic activity of peripheral and uterine blood as influenced by p-aminomethylbenzoic acid (PAMBA) in pgnancy toxemias].
    Sieg U; Flähmig M
    Zentralbl Gynakol; 1969 Dec; 91(51):1662-6. PubMed ID: 5383534
    [No Abstract]   [Full Text] [Related]  

  • 20. [Etiology, pathogenesis, and therapy of critical hemorrhages in pregnancy and during labor].
    Appel W; Ardelt W
    Zentralbl Gynakol; 1971 Feb; 93(8):241-50. PubMed ID: 5316218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.